Close
ACHEMA MIDDLE EAST 2026

New Algorithms That Lead To Personalized Cancer Treatments

When single-cell data is combined with a self-learning algorithm, it is a revelation as to how structural changes can go on to trigger cancer....

A New Advancement In Disease Fighting Through Technology

To grasp the intricate pathology of many diseases today, scientists and researchers have achieved amazing advances in basic science. The ability of the human...

5 Concerns About Future of Developing Biotechnology In 2023

Drugmakers' initial stock offerings, which had been a dependable tradition for years, mostly stopped in 2022. Fewer than two dozen biotech businesses priced initial...

Life-Changing Potential of Artificial Pancreas Technology

Innovative technology could help people with Type 1 diabetes who can't control their condition, and it will be made available to them. Additionally, the...

Technology Advancement In The Biopharma Outsourcing Market

Due to the fact that many contract manufacturing organisations (CMOs) are the only facilities able to produce vaccines and treatments in the enormous volumes...

6 Issues In Pharma-Biotech Patent Disputes To Watch In 2023

Who will file a lawsuit under the UPC first? The deadline for opting out of patents will begin on March 1, 2023, and the UPC...

OPTIMA Has Made AstraZeneca And Mutabor Official Partners

The European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have collaborated on the Innovative Medicines Initiative (IMI), which has announced...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...